Amodiaquine treatment of uncomplicated malaria in children, in an area of chloroquine-resistant Plasmodium falciparum in north-central Nigeria

Annals of Tropical Medicine and Parasitology

Volumn 97, Issue 7, 2003, Pages 663-669

  Molta, N B ^a   Oguche, S ^b   Pam, S D ^a   Omalu, I C J ^a   Afolabi, B M ^c   Odujoko, J B ^d   Amajoh, C N ^d   Adeniji, B ^e   Wuyep, V P ^f   Ekanem, O J ^d  

^a UNIVERSITY OF JOS   (Nigeria)

^b UNIVERSITY OF MAIDUGURI   (Nigeria)

^c WHO   (Nigeria)

^d Federal Ministry of Health   (Nigeria)

^e NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^f Plateau State Ministry of Health   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; FANSIDAR;

ARTICLE; CHILD; CLINICAL TRIAL; CONVALESCENCE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; HEMATOCRIT; HUMAN; INFANT; MALARIA; MALE; NIGERIA; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; TREATMENT OUTCOME;

AMODIAQUINE; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; NIGERIA; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 10744226199     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349803225002417     Document Type: Article

References (17)

1. Anon. (1989). Guidelines for Malaria Control in Nigeria. Lagos: Gabumo Press.
2. Anon. (1990). Guidelines for Malaria Control for Physicians in Nigeria. Lagos: Gabumo Press.
3. Asindi, A. A., Ekanem, E. E., Ibia, E. O. & Nwangwa, M. A. (1993). Upsurge of malaria-related convulsions in a paediatric emergency room in Nigeria. Consequence of emerging resistant Plasmodium falciparum. Tropical and Geographical Medicine, 45, 110-113.
4. Bloland, P. B., Lakritz, E. M., Kazembe, P. M., Were, J. B. D., Steketee, R. & Campbell, C. G. (1993). Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases, 167, 932-937.
5. Brewster, D. R. & Greenwood, B. M. (1993). Seasonal variation of paediatric diseases in the Gambia, West Africa. Annals of Tropical Paediatrics, 13, 133-146.
6. Bruce-Chwatt, L. J., Black, R. H., Canfield, C. J., Clyde, D. F., Peters, W. & Wernsdorfer, W. H. (Eds) (1986). Chemotherapy of Malaria, 2nd Edn. Geneva: World Health Organization.
7. Fleming, A. F. & Werblińska, B. (1982). Anaemia in childhood in the guinea savanna of Nigeria. Annals of Tropical Paediatrics, 2, 161-173.
8. Hatton, C., Peto, T., Bunch, C., Pasvol, G., Russel, S., Singer C., Edwards, G. & Winstanley, P. (1986). Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet, i, 411-413.
9. Krishna, S. & White, N. J. (1996). Pharmacokinetics of quinine, chloroquine and amodiaquine - clinical implications. Clinical Pharmacokinetics, 30, 263-299.
10. Lelijveld, J. & Kortmann, H. (1970). The eosin colour test of Dill Glazko: a simple test to detect chloroquine in urine. Bulletin of the World Health Organization, 42, 477-479.
11. Neftel, K., Woodtly, W., Schmidt, R., Frich, P. & Fehr, J. (1986). Amodiaquine to induce agranulocytosis and liver damage. British Medical Journal, 292, 721-723.
12. Olliaro, P., Nevill, C., LeBras, J., Ringwald, P., Mussano, P., Garner, P. & Brasseur, P. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 348, 1196-1201.
13. Sowunmi, A. (2002). A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology, 96, 227-238.
14. Trape, J. F. (1999). Impact of drug resistance on morbidity and mortality in malaria infections in Africa. Proceedings of the MIM African Malaria Conference, Durban, South Africa, pp. 36-42 (http://mim.nih.gov/ english/achievements/conference.html#durban_report).
15. White, N. J. (1999). Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia, 41, 301-308.
16. World Health Organization (1995). Guidelines for Good Clinical Practice for Trials on Pharmaceutical Products. Technical Report Series No. 850. Geneva: WHO.
17. World Health Organization (1996). Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Document WHO/MAL/96.1077. Geneva: WHO.